253 related articles for article (PubMed ID: 22843797)
1. Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.
Mastri M; Shah Z; McLaughlin T; Greene CJ; Baum L; Suzuki G; Lee T
Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1021-33. PubMed ID: 22843797
[TBL] [Abstract][Full Text] [Related]
2. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen.
Shabbir A; Zisa D; Suzuki G; Lee T
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1888-97. PubMed ID: 19395555
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells and cardiac regeneration: a sophisticated approach depends on trophic effects--what's left over? Focus on "Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency".
Zimmermann O
Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1004-5. PubMed ID: 22972800
[No Abstract] [Full Text] [Related]
5. The Upregulation of Toll-Like Receptor 3 via Autocrine IFN-β Signaling Drives the Senescence of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Through JAK1.
Lee HJ; Choi B; Kim Y; Lee SE; Jin HJ; Lee HS; Chang EJ; Kim SW
Front Immunol; 2019; 10():1659. PubMed ID: 31396213
[TBL] [Abstract][Full Text] [Related]
6. No significant effects of Poly(I:C) on human umbilical cord-derived mesenchymal stem cells in the treatment of B6.MRL-Fas(lpr) mice.
Huang S; Wang D; Gu F; Zhang Z; Deng W; Chen W; Tang X; Yao G; Feng X; Sun L
Curr Res Transl Med; 2016; 64(2):55-60. PubMed ID: 27316386
[TBL] [Abstract][Full Text] [Related]
7. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy.
Li JH; Zhang N; Wang JA
J Endocrinol Invest; 2008 Feb; 31(2):103-10. PubMed ID: 18362500
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair.
Zisa D; Shabbir A; Suzuki G; Lee T
Biochem Biophys Res Commun; 2009 Dec; 390(3):834-8. PubMed ID: 19836359
[TBL] [Abstract][Full Text] [Related]
9. Combined Administration of TLR4 (LPS) and TLR3 (Poly I:C) Ligands to CBA Mice Elevates the Content of Osteogenic MSC by 1.6 Times and Increases Content of Bone Marrow MSC to Intermediate Level between Values Attained by Their Individual Administration.
Gorskaya YF; Tukhvatulin AI; Dzharullaeva AS; Nesterenko VG
Bull Exp Biol Med; 2020 Apr; 168(6):767-772. PubMed ID: 32328942
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells.
Lin H; Shabbir A; Molnar M; Yang J; Marion S; Canty JM; Lee T
J Cell Physiol; 2008 Aug; 216(2):458-68. PubMed ID: 18288639
[TBL] [Abstract][Full Text] [Related]
11. Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.
Shabbir A; Zisa D; Lin H; Mastri M; Roloff G; Suzuki G; Lee T
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1428-38. PubMed ID: 20852053
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair.
Zisa D; Shabbir A; Mastri M; Taylor T; Aleksic I; McDaniel M; Suzuki G; Lee T
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2422-32. PubMed ID: 21963833
[TBL] [Abstract][Full Text] [Related]
14. β-Glucan-supplemented diets increase poly(I:C)-induced gene expression of Mx, possibly via Tlr3-mediated recognition mechanism in common carp (Cyprinus carpio).
Falco A; Miest JJ; Pionnier N; Pietretti D; Forlenza M; Wiegertjes GF; Hoole D
Fish Shellfish Immunol; 2014 Feb; 36(2):494-502. PubMed ID: 24370748
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe
Park J; Kim S; Lim H; Liu A; Hu S; Lee J; Zhuo H; Hao Q; Matthay MA; Lee JW
Thorax; 2019 Jan; 74(1):43-50. PubMed ID: 30076187
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 3 activation in retinal pigment epithelium cells - Mitogen-activated protein kinase pathways of cell death and vascular endothelial growth factor secretion.
Klettner A; Koinzer S; Meyer T; Roider J
Acta Ophthalmol; 2013 May; 91(3):e211-8. PubMed ID: 23387336
[TBL] [Abstract][Full Text] [Related]
17. Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells.
Raicevic G; Najar M; Busser H; Crompot E; Bron D; Toungouz M; Lagneaux L
Sci Rep; 2017 Jun; 7(1):2896. PubMed ID: 28588282
[TBL] [Abstract][Full Text] [Related]
18. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors.
Nguyen BK; Maltais S; Perrault LP; Tanguay JF; Tardif JC; Stevens LM; Borie M; Harel F; Mansour S; Noiseux N
J Cardiovasc Transl Res; 2010 Oct; 3(5):547-58. PubMed ID: 20559784
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional collagenous niche and azacytidine selectively promote time-dependent cardiomyogenesis from human bone marrow-derived MSC spheroids.
Joshi J; Mahajan G; Kothapalli CR
Biotechnol Bioeng; 2018 Aug; 115(8):2013-2026. PubMed ID: 29665002
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.
van den Akker F; de Jager SC; Sluijter JP
Mediators Inflamm; 2013; 2013():181020. PubMed ID: 24391353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
